mutations were not found. Seven patients developed brain metastases and 43% of them had KRAS mutation. In univariate analysis, median overall survival (OS) for KRAS WT patients was longer compared ... PTEN status. In…
advanced lung cancer; however, there are no standard treatment plans for lung cancer with KRAS mutation. Apatinib has been successfully applied as third-line treatment for advanced gastric cancer ... treatment of…
Objective: We attempted to detect EGFR and KRAS mutations in plasma/pleural effusion in patients with advanced non-small- cell lung cancer (NSCLC) by pyrosequencing, to investigate whether plasma ... replace tumor…
mutation was most frequent followed by codon 13 mutation. Five different Missense mutations at KRAS codon 12 (G12S, G12D, G12A, G12V, and G12C) and one substitution type at codon ... most recurrent mutation in addition…
separate and combined survival analyses of MACC1 expression with any of the markers KRAS mutated in codon 12 (KRAS G12) or codon 13 (KRAS G13), BRAFV600 mutation and MSI status ... with the different CRC pathways…
order to compare the gene mutation profiles of patients with or without a KRAS mutation, the clinicopathological data of 858 patients and NGS test results of 1697 patients with colorectal ... TP53 mutant group…
agents give an opportunity to provide a new standard of care. Therefore testing EGFR, KRAS mutations and ALK rearrangements in patients with advanced lung adenocarcinoma should be incorporated into routine ... relevant…
Context KRAS mutations play an important role in pancreatic cancer. GNAS mutations were discovered in intraductal papillary mucinous neoplasms (IPMN). Objectives Our aim was to identify the frequency of KRAS ... with…
women in western countries, but few studies have examined the frequency of mutations in PIK3CA, BRAF, and KRAS in Chinese breast cancer patients. In this study, we conducted sequence analysis ... extracted from 25 cases…
downstream signaling pathway genes was assessed using quantitative real-time polymerase chain reaction. Results: KRAS mutation was detected in 80% of cases but the mutation status do not influence PDAC ... adjacent…
Aims: This retrospective study aims to analyze the frequency of tumor hot spot mutations in KRAS, BRAF and Micro Satellite Instability (MSI) status of tumors in Algerian patients with advanced ... serrated polyposis…
panel of five mononucleotide markers (BAT25, BAT26, NR21, NR22 and NR24). Results: BRAF and KRAS mutations were detected in 4.9% and 31.3% of the tumors patients respectively. Activating mutations ... located in the…
resistant to adjuvant chemotherapy. The current study demonstrates the performance of the cobas® KRAS Mutation Test (cobas test), a TaqMelt polymerase chain reaction (PCR) assay designed to detect 19 mutations…
cancer 80-90% of pancreatic cancer and a lesser frequency with other cancers. Mutations in KRAS gene ... causes constitutively active signaling function leading to cell proliferation and cancer. Most of these KRAS…
advanced lung cancer; however, there are no standard treatment plans for lung cancer with KRAS mutation. Apatinib has been successfully applied as third-line treatment for advanced gastric cancer ... treatment of…
gene in the modules with closely correlated expression levels in the same module. Mutations in KRAS, BRAF and TP53 were assessed using direct sequencing. Microsatellite instability (MSI) was analyzed using ... risk…
well as qPCR methods of mutation detection. Several case studies highlighting the role of KRAS mutations in EGFR therapies in colorectal cancer and multiple mutations in oncodrivers in NSCLC will
evaluated by polymerase chain reaction and sequencing analysis. Although the overall frequency of KRAS mutations (36.6%) seemed to be similar to those reported for other populations, the rate of point ... showed more…
cancer research, few genes have garnered as much attention and significance as KRAS. KRAS mutations are among the most common genetic alterations found in human cancers, particularly in pancreatic, colorectal…
leading cause to cancer mortality and morbidity. In many studies, mutations in the KRAS and BRAF genes are involved in colorectal cancer, and are associated with the primary resistance ... EGFR inhibitors. Objective of…
this study is to find out the prevalence of two known main point mutations of KRAS gene (p.G12V/c.35G>T and p.G13D/c.38G>A) in addition to bioinformatics survey ... were performed by using SWISS-MODEL server and the…
Objective The purpose is to determine if the different Kras mutations found in pancreatic ductal adenocarcinoma (PDA) confer different survivals after adjuvant gemcitabine, docetaxel and capecitabine (GTX) therapy, a…
time The instrument reports the presence or absence of clinically-relevant oncogenic mutations in KRAS, EGFR, BRAF, and/or NRAS in ≤ 2.5 hours per sample. In this study, we tested ... provide a cost effective, quick and…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.